What do weapons and drug discovery have in common? Over the last 24 hours, billions of dollars and a lead investor.
Isomorphic, which is building a unified drug discovery product based on artificial intelligence (AI), is the third company to ...
Isomorphic Labs Inc., a healthcare startup that spun out of Alphabet Inc. in 2021, today announced that it has closed a $600 million funding round. OpenAI backer Thrive Capital led the investment. It ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results